Figure 2From: Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma Comparison of overall survival time in ALK + and ALK- ALCL patients. (A) Kaplan-Meier curves showing significant difference in cumulative survival rate between ALK + and ALK- ALCL patients. (B) Kaplan-Meier curves showing no difference in cumulative survival rate between NPM-ALK + ALCLs and those ALCLs with variant ALK fusions.Back to article page